FDA postpones meetings and inspections, grounds staff to combat COVID-19

FDA is postponing meetings, cancelling most travel and halting most foreign inspections as part of U.S. government-wide steps to contain the COVID-19 outbreak.

Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research (CDER), told staff in an email Tuesday, “We plan to use technology and established agreements with our foreign counterparts to minimize disruptions to the drug supply chain and to applications under review, so that Americans can continue to get their medications.”...